News
FDA Approves Obe-cel for ALL

The US Food and Drug Administration (FDA) has approved obecabtagene autoleucel, or obe-cel (AUTO1, Autolus Therapeutics) for the treatment of…

Devamını Oku »

MedPAC Tackles Accuracy of Medicare Advantage Network Directories

Inaccuracies in Medicare Advantage (MA) directories listing in-network providers — often criticized as being too “narrow” — and flaws in…

Devamını Oku »

Trump Likely to Undo Several of Biden’s Executive Orders on Health

Passing laws to overturn Democrats’ healthcare initiatives might take a while, but there are plenty of Biden administration health policies…

Devamını Oku »

Many Voters Backed Abortion Rights and Donald Trump, a Challenge for Democrats – KFF Health News

Voters in three states — Arizona, Missouri, and Nevada — chose on Tuesday to advance protections for abortion rights in…

Devamını Oku »

Trump 2.0 – KFF Health News

The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of…

Devamını Oku »

AI-driven precision healthcare is here – what you need to know

Dr. Anmol Kapoor, founder of CardiAI and BioAro, is an expert in precision healthcare, artificial intelligence and blockchain technologies. He…

Devamını Oku »

Voters in These Red States Okay Paid Sick Leave – KFF Health News

Voters in Missouri and Nebraska approved ballot measures Tuesday that guarantee paid leave for sick workers. Alaska voters seem poised…

Devamını Oku »

Ivermectin Found to Have Dual Effect in Rosacea

TOPLINE:  Topical ivermectin treatment was found to increase Staphylococcus epidermidis on the skin of patients with rosacea, in addition to…

Devamını Oku »

Regenstrief Institute appoints a new chief information officer

Regenstrief Institute, the India University-affiliated research organization focused on healthcare informatics, data science and electronic health record integration, has appointed…

Devamını Oku »

Year in Review: RSV

This year’s headlines on respiratory syncytial virus (RSV) focused largely on the relatively new vaccines — including a new option,…

Devamını Oku »

Frontline Reports | © 2024 | News